These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 37138650)

  • 1. Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Sun XJ; Li ZY; Chen M
    Rheumatol Immunol Res; 2023 Mar; 4(1):11-21. PubMed ID: 37138650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis.
    Schreiber A; Rousselle A; Becker JU; von Mässenhausen A; Linkermann A; Kettritz R
    Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9618-E9625. PubMed ID: 29078325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil extracellular traps can activate alternative complement pathways.
    Wang H; Wang C; Zhao MH; Chen M
    Clin Exp Immunol; 2015 Sep; 181(3):518-27. PubMed ID: 25963026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The involvement of NETs in ANCA-associated vasculitis.
    Shiratori-Aso S; Nakazawa D
    Front Immunol; 2023; 14():1261151. PubMed ID: 37781373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation.
    Ohlsson S; Holm L; Hansson C; Ohlsson SM; Gunnarsson L; Pettersson Å; Skattum L
    PLoS One; 2019; 14(6):e0218272. PubMed ID: 31216309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil Extracellular Traps in ANCA-Associated Vasculitis.
    Söderberg D; Segelmark M
    Front Immunol; 2016; 7():256. PubMed ID: 27446086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of ANCA-associated vasculitis: An update.
    Jarrot PA; Kaplanski G
    Autoimmun Rev; 2016 Jul; 15(7):704-13. PubMed ID: 26970490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement system activation in ANCA vasculitis: A translational success story?
    Kallenberg CG; Heeringa P
    Mol Immunol; 2015 Nov; 68(1):53-6. PubMed ID: 26597208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement in ANCA-associated vasculitis: mechanisms and implications for management.
    Chen M; Jayne DRW; Zhao MH
    Nat Rev Nephrol; 2017 Jun; 13(6):359-367. PubMed ID: 28316335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promotion of hypercoagulability in antineutrophil cytoplasmic antibody-associated vasculitis by C5a-induced tissue factor-expressing microparticles and neutrophil extracellular traps.
    Huang YM; Wang H; Wang C; Chen M; Zhao MH
    Arthritis Rheumatol; 2015 Oct; 67(10):2780-90. PubMed ID: 26097236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rise of complement in ANCA-associated vasculitis: from marginal player to target of modern therapy.
    Trivioli G; Vaglio A
    Clin Exp Immunol; 2020 Dec; 202(3):403-406. PubMed ID: 32946609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis and therapeutic interventions for ANCA-associated vasculitis.
    Nakazawa D; Masuda S; Tomaru U; Ishizu A
    Nat Rev Rheumatol; 2019 Feb; 15(2):91-101. PubMed ID: 30542206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement in ANCA-associated vasculitis.
    Charles Jennette J; Xiao H; Hu P
    Semin Nephrol; 2013 Nov; 33(6):557-64. PubMed ID: 24161040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody（ANCA）-associated vasculitis.
    Tsukui D; Kimura Y; Kono H
    J Transl Autoimmun; 2021; 4():100094. PubMed ID: 33912820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Complement System and ANCA Associated Vasculitis in the Era of Anti-Complement Drugs.
    Kimoto Y; Horiuchi T
    Front Immunol; 2022; 13():926044. PubMed ID: 35812453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement Factor H Inhibits Anti-Neutrophil Cytoplasmic Autoantibody-Induced Neutrophil Activation by Interacting With Neutrophils.
    Chen SF; Wang FM; Li ZY; Yu F; Chen M; Zhao MH
    Front Immunol; 2018; 9():559. PubMed ID: 29616045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant thrombomodulin ameliorates autoimmune vasculitis via immune response regulation and tissue injury protection.
    Watanabe-Kusunoki K; Nakazawa D; Kusunoki Y; Kudo T; Hattanda F; Nishio S; Masuda S; Tomaru U; Kondo T; Atsumi T; Ishizu A
    J Autoimmun; 2020 Mar; 108():102390. PubMed ID: 31883830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The expression and clinical significance of neutrophil myeloperoxidase in patients with myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Liu Y; Peng XC; Xu JN; Zheng MJ; Shuai ZW
    Zhonghua Nei Ke Za Zhi; 2022 Sep; 61(9):1016-1022. PubMed ID: 36008294
    [No Abstract]   [Full Text] [Related]  

  • 19. Formation and Disordered Degradation of Neutrophil Extracellular Traps in Necrotizing Lesions of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Masuda S; Nonokawa M; Futamata E; Nishibata Y; Iwasaki S; Tsuji T; Hatanaka Y; Nakazawa D; Tanaka S; Tomaru U; Kawakami T; Atsumi T; Ishizu A
    Am J Pathol; 2019 Apr; 189(4):839-846. PubMed ID: 30677396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of the Pathogenesis of ANCA-Associated Vasculitis.
    Xiao H; Hu P; Falk RJ; Jennette JC
    Kidney Dis (Basel); 2016 Mar; 1(4):205-15. PubMed ID: 27536680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.